Vaccine Export Prices on a Strong Ascent

Uruguay’s vaccine export market is experiencing a meaningful upswing,with prices reaching levels not seen since September 2022.Preliminary data from the National Meat Institute (INAC) indicates that the average export price per ton of vaccine meat reached US $4,790 in March 2025. This represents a 2% increase compared to February and a ample 21% jump compared to the US $3,964 recorded in march 2024. The upward trend suggests a strengthening global demand for Uruguayan vaccine products.

March Figures Highlight Robust Growth

The final week of March saw even higher average values, peaking at US $4,841 per ton. The year-to-date average stands at US $4,720 per ton, reflecting a 16.6% recovery compared to the same period last year. This positive momentum underscores the competitiveness and quality of uruguayan vaccine in the international market.

Volume Growth Accompanies Price Surge

Alongside the price increases, export volumes have also risen. In March, Uruguay exported 43,396 tons of vaccine meat, an 8.5% increase compared to the 40,003 tons exported in March of the previous year. This simultaneous growth in both price and volume points to a healthy and expanding export sector.

Key Export Destinations: A Shifting Landscape

The United States has emerged as the primary destination for Uruguayan vaccine exports, importing 17,297 tons in March. This represents a remarkable 51% year-on-year increase, highlighting the growing importance of the US market. in contrast, China, previously a leading importer, saw a 23% decrease, receiving 13,518 tons. This shift could be attributed to various factors, including changing consumer preferences, trade dynamics, or increased domestic production in China.

The European Union also demonstrated strong growth, with imports increasing by 44% to reach 4,174 tons. This indicates a growing demand for Uruguayan vaccine within the EU market, perhaps driven by factors such as quality perceptions and trade agreements.

Market Dynamics and Future Outlook

The surge in Uruguayan vaccine exports reflects a complex interplay of global market dynamics. Factors such as increasing global demand for protein, shifts in consumer preferences, and trade agreements all contribute to the observed trends. while the US market is currently driving growth, the fluctuations in demand from China highlight the importance of diversifying export destinations. The continued growth in the EU market offers another avenue for expansion.

Looking ahead,the Uruguayan vaccine industry is poised for continued growth,provided it can adapt to evolving market demands and maintain its competitive edge. Investment in lasting production practices and quality control will be crucial to ensuring long-term success.